Back to dashboard
CommercialAdministrativeLow impact

08.01.25i, Ramucirumab (Cyramza®)

Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
May 27, 2026
We identified it
Jun 19, 2026
Days to comply
—

Summary

The Ramucirumab (Cyramza®) pharmacy policy has been reissued with an effective date of May 27, 2026. This is a routine policy reissuance for this cancer medication, though specific changes are not detailed in the provided content.

Action Required

Action needed
By May 27, 2026: Review the updated Ramucirumab (Cyramza®) policy at the provided URL to identify any specific changes to coverage, prior authorization requirements, or billing procedures. Update billing protocols and prior authorization workflows as needed based on the full policy content.

Related policy hubs